The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).
Background: Cross transmission via skin contact and environmental media is the main route for common outbreak of health care-associated infection which more likely to be improved or prevented by infection control program. Silver Knight uses silver ions to disrupt the normal enzymatic activities of bacteria for reducing microbial growth within, and on, the surface of the breathing systems. It functions as a safe, quick and effective catalyst to deactivate pathogenic bacteria and prevent their proliferation. However, there was no study comparing the standard ventilator circuit with Silver Knight. This study focuses on the effectiveness of antimicrobial breathing system in MDRO which including carbapenem-resistant, vancomycin-resistant and multi-drug resistant. Study Design: This is a prospective, randomized study in a single hospital in the intensive care unit. Methods: In this study, we conduct a cluster-randomized crossover, single-centre trial. There are two groups: 1. Control group: standard ventilator circuit in odd number month. 2. Experimental group: Silver Knight in even number month This study is expected to recruit 200 subjects. During this period, the ventilator circuits are all routinely used, only the tubing will not be discarded after use for specimen collection.And the MDRO on the surfaces of ventilator circuits will be analyzed and evaluated. Effect: We expect the antimicrobial breathing system could be more effectively than the standard ventilator circuit. The policy related to current ventilator circuit will be revised according to the results of this study. Key words: Antimicrobial Breathing system, ventilator circuits, multidrug-resistant organisms (MDRO)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
24
Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including: * Staphyloccus epidermis * Pseudomonas aeruginosa * Klebsiella pneumoniae * Acinetobacter calcoaceticus * Escherichia coli
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, Taiwan
bacterial contamination
comparison of the two ventilator systems
Time frame: one month
bacterial detection rate
comparison of the two ventilator systems
Time frame: one month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.